肝细胞敲除甘油三酯合成酶DGAT2可减轻小鼠脂肪肝且不增加炎症或纤维化
该研究通过喂养富含果糖、饱和脂肪和胆固醇的饮食诱导小鼠非酒精性脂肪性肝病(NAFLD)样疾病,发现肝细胞特异性Dgat2缺失使肝脏甘油三酯降低约70%,且未伴随炎症或纤维化增加,胰岛素和葡萄糖代谢亦无变化。作者认为肝DGAT2缺失可减少饮食诱导的肝脂肪变性,并支持开发DGAT2抑制剂作为治疗NAFLD的策略。
要点
- 肝细胞特异性Dgat2缺失使饮食诱导NAFLD小鼠肝脏甘油三酯降低约70%。
- Dgat2缺失未伴随炎症或纤维化增加,胰岛素和葡萄糖代谢无变化。
- 作者认为该结果支持开发DGAT2抑制剂用于治疗NAFLD。
核心结论
- 本研究提示肝DGAT2缺失可成功减少饮食诱导的肝脂肪变性,并支持开发DGAT2抑制剂作为治疗NAFLD及预防下游后果的策略。
研究设计与样本
- 研究通过给小鼠喂养富含果糖、饱和脂肪和胆固醇的饮食诱导NAFLD样疾病,并采用肝细胞特异性Dgat2缺失模型。
主要发现
- 肝细胞特异性Dgat2缺失降低了从头脂肪生成基因的表达,并使肝脏甘油三酯降低约70%。
- 肝脂肪变性减少未伴随炎症或纤维化增加,胰岛素和葡萄糖代谢无变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nonalcoholic fatty liver disease (NAFLD) is characterized by excess lipid accumulation in hepatocytes and represents a huge public health problem owing to its propensity to progress to nonalcoholic steatohepatitis, fibrosis, and liver failure. The lipids stored in hepatic steatosis (HS) are primarily triglycerides (TGs) synthesized by two acyl-CoA:diacylglycerol acyltransferase (DGAT) enzymes. Either DGAT1 or DGAT2 catalyzes this reaction, and these enzymes have been suggested to differentially utilize exogenous or endogenously synthesized fatty acids, respectively. DGAT2 has been linked to storage of fatty acids from de novo lipogenesis, a process increased in NAFLD. However, whether DGAT2 is more responsible for lipid accumulation in NAFLD and progression to fibrosis is currently unknown. Also, it is unresolved whether DGAT2 can be safely inhibited as a therapy for NAFLD. Here, we induced NAFLD-like disease in mice by feeding a diet rich in fructose, saturated fat, and cholesterol and found that hepatocyte-specific Dgat2 deficiency reduced expression of de novo lipogenesis genes and lowered liver TGs by ~70%. Importantly, the reduction in steatosis was not accompanied by increased inflammation or fibrosis, and insulin and glucose metabolism were unchanged. Conclusion: This study suggests that hepatic DGAT2 deficiency successfully reduces diet-induced HS and supports development of DGAT2 inhibitors as a therapeutic strategy for treating NAFLD and preventing downstream consequences.
引用
- Gluchowski NL, Gabriel KR, Chitraju C, et al. Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice. Hepatology. 2019. PMID: 31081165. doi:10.1002/hep.30765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。